[시장보고서]EPA 및 DHA 시장 보고서 : 유형별, 유래별, 용도별, 지역별(2025-2033년)

EPA 및 DHA 시장 보고서 : 유형별, 유래별, 용도별, 지역별(2025-2033년)

EPA & DHA Market Report by Type (Eicosapentaenoic Acid, Docosahexaenoic Acid ), Source, Application, and Region 2025-2033

상품코드 : 1636014

리서치사 : IMARC

발행일 : 2025년 01월

페이지 정보 : 영문 128 Pages

라이선스 & 가격 (부가세 별도)

US $ 2,999

￦ 4,442,000

PDF & Excel (Single User License)

PDF & Excel 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 불가능하며, 텍스트 등의 Copy&Paste도 불가능합니다.

US $ 3,999

￦ 5,923,000

PDF & Excel (5 User License)

PDF & Excel 보고서를 동일 기업의 5명까지 이용할 수 있는 라이선스입니다. 텍스트 등의 Copy&Paste가 불가능합니다. 인쇄는 5부까지 가능하며, 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 4,999

￦ 7,404,000

PDF & Excel (Corporate License)

ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.

한글목차

샘플 요청 목록에 추가

EPA 및 DHA 시장의 세계 시장 규모는 2024년에 19억 9,050만 달러에 달했습니다. 향후 IMARC Group은 이 시장이 2033년까지 33억 6,960만 달러에 달할 것으로 예상하며, 2025년부터 2033년까지 5.72%의 연평균 성장률(CAGR)을 보일 것으로 예측하고 있습니다. 오메가 3 지방산의 건강 효과에 대한 소비자의 인식 증가, 기능성 식품 및 보충제에 대한 수요 증가, 어업에서 지속가능하고 환경 친화적인 조달 방법의 확산은 시장을 이끄는 주요 요인 중 일부입니다.

EPA(에이코사펜타엔산)와 DHA(도코사헥사엔산)는 유사한 화학구조를 가진 장쇄 고도불포화 오메가 3 지방산을 말하며, 인간의 건강에 필수적인 영양소입니다. 일반적으로 연어, 고등어, 정어리, 정어리, 해조류 등 지방이 많은 생선에 함유된 EPA, DHA는 체내에서 합성되지 않기 때문에 식단이나 보충제를 통해 섭취해야 합니다. 생선이나 보충제를 통해 섭취한 EPA와 DHA는 생체 이용률이 높아 인체에 비교적 쉽게 흡수되어 세포막 등 필요한 구조물로 흡수되며, EPA와 DHA는 인지기능 저하를 예방하고 항염증 작용을 통해 심장병, 콜레스테롤, 관절염 등 만성질환의 위험을 낮추기 때문에 뇌의 기능과 발달에 중요합니다. 또한 EPA와 DHA는 면역 체계를 조절하고 피부 건강에 도움을 주며, 노화 관련 황반변성 위험을 최소화하는 데도 중요합니다.

EPA 및 DHA 시장 동향:

세계 시장은 EPA 및 DHA를 함유한 보충제 및 기능성 식품에 대한 수요 증가에 의해 크게 견인되고 있습니다. 이는 대중, 특히 노년층에서 심장병, 당뇨병, 암과 같은 만성질환의 발병률이 증가하고 있기 때문입니다. 이에 따라 건강과 피트니스에 대한 소비자의 인식이 높아지면서 EPA 및 DHA 강화 식품에 대한 수요가 증가하고 있습니다. 또한, 유아용 조제분유와 반려동물 사료에 EPA 및 DHA의 사용량이 증가하면서 시장 성장에 유리한 기회를 창출하고 있습니다. 또한, 제조업체들이 고순도, 고농도의 EPA 및 DHA 보충제 및 기능성 식품을 생산할 수 있도록 하는 가공 기술의 지속적인 발전도 시장에 활력을 불어넣고 있습니다. 소비자들 사이에서 식물성 채식주의가 확산됨에 따라 조류 기반 보충제 및 식품과 같은 식물성 EPA 및 DHA의 이용이 증가하고 있습니다. 식품 및 보충제 관련 규제 및 표시 요건의 패러다임 변화로 인해 시장은 더욱 활성화되고 있으며, 이에 따라 기업들은 새로운 규정을 준수하기 위해 처방 및 마케팅 전략을 조정하고 있습니다. 그 외 시장 성장에 기여하는 다른 요인으로는 급속한 도시화, 수산업에서 지속가능하고 친환경적인 조달 방법의 확산, 가처분 소득 수준 증가, 주요 기업의 광범위한 R&D 활동 등이 있습니다.

본 보고서에서 다루는 주요 질문

세계 EPA 및 DHA 시장은 지금까지 어떻게 성장해 왔을까?
세계 EPA 및 DHA 시장의 촉진요인, 저해요인, 기회요인은 무엇인가?
각 촉진요인, 억제요인 및 기회가 세계 EPA 및 DHA 시장에 미치는 영향은 무엇인가?
주요 지역 시장은?
가장 매력적인 EPA 및 DHA 시장은 어느 국가인가?
유형별 시장 분석은?
EPA 및 DHA 시장에서 가장 매력적인 유형은?
원산지별 시장 내역은?
EPA 및 DHA 시장에서 가장 매력적인 원료는?
용도별 시장 내역은?
EPA 및 DHA 시장에서 가장 매력적인 용도는?
세계 EPA 및 DHA 시장의 경쟁 구도는?
세계 EPA 및 DHA 시장의 주요 플레이어/기업은?

시장 구조
주요 기업
주요 기업 개요
- AlgiSy BioSciences Inc.
- Arctic Nutrition AG
- BASF SE
- Biosearch Sau
- Corbion NV
- Croda International PLC
- KD Pharma Group
- Koninklijke DSM NV
- Nordic Naturals Inc
- Novasep Holding SAS
- Novotech Nutraceuticals Inc
- Omega Protein Corporation
- Polaris

ksm

영문 목차

영문목차

The global EPA & DHA market size reached USD 1,990.5 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 3,369.6 Million by 2033, exhibiting a growth rate (CAGR) of 5.72% during 2025-2033. The increasing consumer awareness about the health benefits of omega-3 fatty acids, rising demand for functional foods and supplements, and the growing prevalence of sustainable and eco-friendly sourcing practices in the fishing industry represent some of the key factors driving the market.

EPA (eicosapentaenoic acid) and DHA (docosahexaenoic acid) refer to long-chain polyunsaturated omega-3 fatty acids with similar chemical structures that are essential for human health. Usually found in fatty fish, such as salmon, mackerel, sardines and algae, EPA and DHA are not synthesized by the human body and must be obtained through diet or supplementation. EPA and DHA from fish and supplements are highly bioavailable, therefore they are absorbed by the human body relatively easily and can be incorporated into cell membranes and other structures where they are needed. EPA and DHA are important for brain function and development as they protect against cognitive decline and their anti-inflammatory properties help to reduce the risk of chronic diseases, such as heart disease, cholesterol, and arthritis. In addition to this, EPA and DHA are important for regulating the immune system, benefitting skin health and minimizing the risks of age-related macular degeneration.

EPA & DHA Market Trends:

The global market is majorly driven by the augmenting demand for supplements and functional foods containing EPA and DHA. This can be attributed to the rising incidences of chronic diseases, such as heart disease, diabetes, and cancer among the masses, particularly the geriatric population. In line with this, the increasing awareness among consumers regarding health and fitness is also propelling the demand for EPA and DHA fortified foods. Moreover, the increasing usage of EPA and DHA in infant formula and pet food is creating lucrative growth opportunities in the market. Besides this, continual technological advancements in the processing techniques enabling manufacturers to produce high-purity and high-concentration EPA and DHA supplements and functional foods are providing an impetus to the market. The growing adoption of plant-based vegan diets among the consumer base is resulting in a higher uptake of plant-based sources of EPA and DHA, such as algae-based supplements and foods. The market is further fueled by the paradigm shift in regulations and labeling requirements for food and supplements, resulting in companies adjusting their formulations and marketing strategies to comply with new rules. Some of the other factors contributing to the market include rapid urbanization, growing prevalence of sustainable and eco-friendly sourcing practices in the fishing industry, inflating disposable income levels, and extensive research and development (R&D) activities conducted by the key players.

Key Market Segmentation:

Type Insights:

Eicosapentaenoic Acid (EPA)
Docosahexaenoic Acid (DHA)

Source Insights:

Fish Oil
Algae Oil
Krill Oil
Others

Application Insights:

Infant Formulae
Dietary Supplements
Fortified Food and Beverages
Pharmaceuticals
Others
A detailed breakup and analysis of the EPA & DHA market based on the application has also been provided in the report. This includes infant formulae, dietary supplements, fortified food and beverages, pharmaceuticals, and others. According to the report, dietary supplements accounted for the largest market share.

Regional Insights:

North America
United States
Canada
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Asia Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, Asia Pacific was the largest market for EPA & DHA. Some of the factors driving the Asia Pacific EPA & DHA market included the growing geriatric population, continual technological advancements in sustainable fishing practices, increasing awareness regarding health and fitness, etc.

Competitive Landscape:

The report has also provided a comprehensive analysis of the competitive landscape in the global EPA & DHA market. Competitive analysis such as market structure, market share by key players, player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided. Some of the companies covered include AlgiSy BioSciences Inc., Arctic Nutrition AG, BASF SE, Biosearch Sau, Corbion NV, Croda International PLC, KD Pharma Group, Koninklijke DSM NV, Nordic Naturals Inc, Novasep Holding SAS, Novotech Nutraceuticals Inc, Omega Protein Corporation, Polaris, etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

Key Questions Answered in This Report:

How has the global EPA & DHA market performed so far, and how will it perform in the coming years?
What are the drivers, restraints, and opportunities in the global EPA & DHA market?
What is the impact of each driver, restraint, and opportunity on the global EPA & DHA market?
What are the key regional markets?
Which countries represent the most attractive EPA & DHA market?
What is the breakup of the market based on the type?
Which is the most attractive type in the EPA & DHA market?
What is the breakup of the market based on the source?
Which is the most attractive source in the EPA & DHA market?
What is the breakup of the market based on application?
Which is the most attractive application in the EPA & DHA market?
What is the competitive structure of the global EPA & DHA market?
Who are the key players/companies in the global EPA & DHA market?

1 Preface

2 Scope and Methodology

2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

4.1 Overview
4.2 Key Industry Trends

5 Global EPA & DHA Market

5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast

6 Market Breakup by Type

6.1 Eicosapentaenoic Acid (EPA)
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
6.2 Docosahexaenoic Acid (DHA)
- 6.2.1 Market Trends
- 6.2.2 Market Forecast

7 Market Breakup by Source

7.1 Fish Oil
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
7.2 Algae Oil
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
7.3 Krill Oil
- 7.3.1 Market Trends
- 7.3.2 Market Forecast
7.4 Others
- 7.4.1 Market Trends
- 7.4.2 Market Forecast

8 Market Breakup by Application

8.1 Infant Formulae
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
8.2 Dietary Supplements
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
8.3 Fortified Food and Beverages
- 8.3.1 Market Trends
- 8.3.2 Market Forecast
8.4 Pharmaceuticals
- 8.4.1 Market Trends
- 8.4.2 Market Forecast
8.5 Others
- 8.5.1 Market Trends
- 8.5.2 Market Forecast

9 Market Breakup by Region

9.1 North America
- 9.1.1 United States
  - 9.1.1.1 Market Trends
  - 9.1.1.2 Market Forecast
- 9.1.2 Canada
  - 9.1.2.1 Market Trends
  - 9.1.2.2 Market Forecast
9.2 Asia-Pacific
- 9.2.1 China
  - 9.2.1.1 Market Trends
  - 9.2.1.2 Market Forecast
- 9.2.2 Japan
  - 9.2.2.1 Market Trends
  - 9.2.2.2 Market Forecast
- 9.2.3 India
  - 9.2.3.1 Market Trends
  - 9.2.3.2 Market Forecast
- 9.2.4 South Korea
  - 9.2.4.1 Market Trends
  - 9.2.4.2 Market Forecast
- 9.2.5 Australia
  - 9.2.5.1 Market Trends
  - 9.2.5.2 Market Forecast
- 9.2.6 Indonesia
  - 9.2.6.1 Market Trends
  - 9.2.6.2 Market Forecast
- 9.2.7 Others
  - 9.2.7.1 Market Trends
  - 9.2.7.2 Market Forecast
9.3 Europe
- 9.3.1 Germany
  - 9.3.1.1 Market Trends
  - 9.3.1.2 Market Forecast
- 9.3.2 France
  - 9.3.2.1 Market Trends
  - 9.3.2.2 Market Forecast
- 9.3.3 United Kingdom
  - 9.3.3.1 Market Trends
  - 9.3.3.2 Market Forecast
- 9.3.4 Italy
  - 9.3.4.1 Market Trends
  - 9.3.4.2 Market Forecast
- 9.3.5 Spain
  - 9.3.5.1 Market Trends
  - 9.3.5.2 Market Forecast
- 9.3.6 Russia
  - 9.3.6.1 Market Trends
  - 9.3.6.2 Market Forecast
- 9.3.7 Others
  - 9.3.7.1 Market Trends
  - 9.3.7.2 Market Forecast
9.4 Latin America
- 9.4.1 Brazil
  - 9.4.1.1 Market Trends
  - 9.4.1.2 Market Forecast
- 9.4.2 Mexico
  - 9.4.2.1 Market Trends
  - 9.4.2.2 Market Forecast
- 9.4.3 Others
  - 9.4.3.1 Market Trends
  - 9.4.3.2 Market Forecast
9.5 Middle East and Africa
- 9.5.1 Market Trends
- 9.5.2 Market Breakup by Country
- 9.5.3 Market Forecast

10 Drivers, Restraints, and Opportunities

10.1 Overview
10.2 Drivers
10.3 Restraints
10.4 Opportunities

11 Value Chain Analysis

12 Porters Five Forces Analysis

12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
- 14.3.1 AlgiSy BioSciences Inc.
  - 14.3.1.1 Company Overview
  - 14.3.1.2 Product Portfolio
- 14.3.2 Arctic Nutrition AG
  - 14.3.2.1 Company Overview
  - 14.3.2.2 Product Portfolio
- 14.3.3 BASF SE
  - 14.3.3.1 Company Overview
  - 14.3.3.2 Product Portfolio
  - 14.3.3.3 Financials
  - 14.3.3.4 SWOT Analysis
- 14.3.4 Biosearch Sau
  - 14.3.4.1 Company Overview
  - 14.3.4.2 Product Portfolio
- 14.3.5 Corbion NV
  - 14.3.5.1 Company Overview
  - 14.3.5.2 Product Portfolio
  - 14.3.5.3 Financials
- 14.3.6 Croda International PLC
  - 14.3.6.1 Company Overview
  - 14.3.6.2 Product Portfolio
  - 14.3.6.3 Financials
  - 14.3.6.4 SWOT Analysis
- 14.3.7 KD Pharma Group
  - 14.3.7.1 Company Overview
  - 14.3.7.2 Product Portfolio
- 14.3.8 Koninklijke DSM NV
  - 14.3.8.1 Company Overview
  - 14.3.8.2 Product Portfolio
  - 14.3.8.3 Financials
  - 14.3.8.4 SWOT Analysis
- 14.3.9 Nordic Naturals Inc
  - 14.3.9.1 Company Overview
  - 14.3.9.2 Product Portfolio
- 14.3.10 Novasep Holding SAS
  - 14.3.10.1 Company Overview
  - 14.3.10.2 Product Portfolio
- 14.3.11 Novotech Nutraceuticals Inc
  - 14.3.11.1 Company Overview
  - 14.3.11.2 Product Portfolio
  - 14.3.11.3 SWOT Analysis
- 14.3.12 Omega Protein Corporation
  - 14.3.12.1 Company Overview
  - 14.3.12.2 Product Portfolio
- 14.3.13 Polaris
  - 14.3.13.1 Company Overview
  - 14.3.13.2 Product Portfolio

Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

한글목차

EPA 및 DHA 시장 동향:

본 보고서에서 다루는 주요 질문

목차

제1장 서문

제2장 조사 범위와 조사 방법

제3장 주요 요약

제4장 소개

제5장 세계의 EPA 및 DHA 시장

제6장 시장 내역 : 유형별

제7장 시장 내역 : 유래별

제8장 시장 내역 : 용도별

제9장 시장 내역 : 지역별

제10장 촉진요인, 억제요인, 기회

제11장 밸류체인 분석

제12장 Porter's Five Forces 분석

제13장 가격 분석

제14장 경쟁 구도